Updates in kidney cancer to look out for at ASCO 2024

Updates in kidney cancer to look out for at ASCO 2024

Key takeaways from ASCO 2024: advances in kidney cancer biomarkers and neoadjuvant therapyПодробнее

Key takeaways from ASCO 2024: advances in kidney cancer biomarkers and neoadjuvant therapy

Episode 9: ASCO Annual Meeting 2024 Commentary: Kidney Cancer - The View on GUПодробнее

Episode 9: ASCO Annual Meeting 2024 Commentary: Kidney Cancer - The View on GU

ASCO 2024 Top 5 Kidney & Bladder Cancer Trials | Monty Pal, MD City of HopeПодробнее

ASCO 2024 Top 5 Kidney & Bladder Cancer Trials | Monty Pal, MD City of Hope

ASCO 2024: Game-Changing GU Oncology Updates w/ Dr. Monte Pal & Dr. Petros Grivas | URO Ep. 178Подробнее

ASCO 2024: Game-Changing GU Oncology Updates w/ Dr. Monte Pal & Dr. Petros Grivas | URO Ep. 178

2024 ASCO Kidney Cancer HighlightsПодробнее

2024 ASCO Kidney Cancer Highlights

Episode 3: ASCO GU 2024 Commentary: Kidney Cancer - The View on GU | with Lalani & WallisПодробнее

Episode 3: ASCO GU 2024 Commentary: Kidney Cancer - The View on GU | with Lalani & Wallis

ASCO® GU Data Updates in Frontline Kidney Cancer: Was Anything Practice Changing?Подробнее

ASCO® GU Data Updates in Frontline Kidney Cancer: Was Anything Practice Changing?

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023

2024 ASCO Genitourinary Kidney Cancer HighlightsПодробнее

2024 ASCO Genitourinary Kidney Cancer Highlights

GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564Подробнее

GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564